Wall Street rebounds as Treasury yields fall; Moderna soars on the back of its melanoma vaccine - Il Sole 24 ORE

Wall Street opened the session on a firmer footing, with major indices rebounding as Treasury yields pulled back from recent highs. The move in the bond market provided a degree of relief for equities, particularly for growth-oriented sectors that tend to be more sensitive to shifts in borrowing costs. A calmer rate environment can ease valuation pressure, though investors are likely to remain attentive to the underlying drivers of the yield movement, including inflation data and Federal Reserve policy expectations.

In company-specific news, Moderna drew sharp attention after its shares surged on the back of progress with its melanoma vaccine. The development highlights the potential for therapeutic vaccines to broaden the company's pipeline beyond its COVID-19 franchise. While the clinical and commercial trajectory remains to be seen, the market's reaction underscores how single-product catalysts can still drive outsized moves in individual names, even when the broader tape is dominated by macro forces.

Looking ahead, the key question for the market is whether the pullback in yields marks a durable trend or a temporary consolidation. Traders will likely watch upcoming economic releases and any commentary from Fed officials for signals, while Moderna's news keeps the focus on biotech innovation as a distinct source of market-moving headlines.